Quanterix Revenue 2016-2020 | QTRX

Quanterix revenue from 2016 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Quanterix Annual Revenue
(Millions of US $)
2019 $57
2018 $38
2017 $23
2016 $18
2015 $12
Quanterix Quarterly Revenue
(Millions of US $)
2020-03-31 $16
2019-12-31 $16
2019-09-30 $15
2019-06-30 $14
2019-03-31 $12
2018-12-31 $11
2018-09-30 $11
2018-06-30 $9
2018-03-31 $8
2017-12-31 $7
2017-09-30 $6
2017-06-30 $5
2017-03-31 $5
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.945B $0.057B
Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. The company services include Simoa Accelerator Lab and custom assay development services. Quanterix Corporation is based in LEXINGTON, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $177.124B 33.24
Medtronic (MDT) Ireland $134.640B 21.87
Stryker (SYK) United States $70.344B 27.28
Boston Scientific (BSX) United States $55.768B 32.22
Lonza Group Ag (LZAGY) Switzerland $46.044B 0.00
Baxter (BAX) United States $42.068B 25.73
Terumo (TRUMY) Japan $28.809B 36.83
Zimmer Biomet Holdings (ZBH) United States $28.652B 23.78
EssilorLuxottica Societe Anonyme (ESLOY) France $28.072B 0.00
ResMed (RMD) United States $25.339B 36.80
Sunny Optical Technology (SNPTF) China $20.401B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $15.045B 68.05
Insulet (PODD) United States $13.389B 566.50
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.636B 51.04
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.061B 12.12
Canopy Growth (CGC) Canada $6.650B 0.00
Hill-Rom Holdings (HRC) United States $6.384B 15.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.311B 0.00
Neogen (NEOG) United States $4.168B 69.64
Haemonetics (HAE) United States $4.002B 26.67
ICU Medical (ICUI) United States $3.727B 28.58
Envista Holdings (NVST) United States $3.647B 24.87
Abcam (ABCZY) $3.548B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.538B 0.00
Agios Pharmaceuticals (AGIO) United States $2.913B 0.00
National Vision Holdings (EYE) United States $2.828B 439.63
NuVasive (NUVA) United States $2.699B 37.62
TG Therapeutics (TGTX) United States $2.058B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.013B 185.38
AtriCure (ATRC) United States $1.896B 0.00
MacroGenics (MGNX) United States $1.504B 0.00
Aphria (APHA) Canada $1.333B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aurora Cannabis (ACB) Canada $1.180B 0.00
Cerus (CERS) United States $1.172B 0.00
Omeros (OMER) United States $1.162B 0.00
Cardiovascular Systems (CSII) United States $1.092B 0.00
OraSure Technologies (OSUR) United States $1.041B 0.00
InMode (INMD) Israel $0.989B 24.94
Lantheus Holdings (LNTH) United States $0.919B 12.73
Owens & Minor (OMI) United States $0.878B 19.67
PetIQ (PETQ) United States $0.877B 25.32
Phibro Animal Health (PAHC) United States $0.816B 16.26
Meridian Bioscience (VIVO) United States $0.791B 18.27
Vapotherm (VAPO) United States $0.743B 0.00
BioLife Solutions (BLFS) United States $0.721B 376.17
VAREX IMAGING (VREX) United States $0.649B 16.12
Surmodics (SRDX) United States $0.643B 70.52
Zynex (ZYXI) United States $0.628B 54.82
LeMaitre Vascular (LMAT) United States $0.602B 36.74
Eagle Pharmaceuticals (EGRX) United States $0.592B 83.19
Cytosorbents (CTSO) United States $0.407B 0.00
Viemed Healthcare (VMD) United States $0.404B 14.44
Neptune Wellness Solutions (NEPT) Canada $0.339B 0.00
HEXO (HEXO) $0.333B 0.00
Utah Medical Products (UTMD) $0.293B 25.16
InfuSystems Holdings (INFU) United States $0.270B 149.44
Organigram Holdings (OGI) Canada $0.235B 0.00
Female Health (VERU) United States $0.214B 0.00
Chimerix (CMRX) United States $0.201B 0.00
Bovie Medical (APYX) United States $0.176B 0.00
Exagen (XGN) United States $0.170B 0.00
Surface Oncology (SURF) United States $0.168B 0.00
Fonar (FONR) United States $0.168B 14.88
Wound Management Technologies (SMTI) United States $0.166B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.133B 0.00
Liberty Health Sciences (LHSIF) Canada $0.126B 0.00
Evolus (EOLS) United States $0.125B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Chembio Diagnostics (CEMI) United States $0.115B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Capricor Therapeutics (CAPR) United States $0.087B 0.00
MTech Acquisition (KERN) United States $0.086B 0.00
United-Guardian (UG) United States $0.071B 15.88
Nephros (NEPH) United States $0.068B 0.00
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Akers Biosciences Inc (AKER) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00